VDR and colorectal cancer: MeTC7 inhibits radiotherapy (RT)-induced PD-L1 expression in vivo: MC38 colorectal cancer cell-based syngeneic animal model [26] in which VDR and PD-L1 overexpression co-occurs under radiation therapy was employed to estimate the efficacy of MeTC7.